|
|||||
|
|
| 血管内皮生长因子与肾细胞癌 | |
| 引用本文： | 周术奎,王顺平,王跃闽. 血管内皮生长因子与肾细胞癌[J]. 国际肿瘤学杂志, 2012, 39(2): 148-151 |
| 作者姓名： | 周术奎 王顺平 王跃闽 |
| 作者单位： | 同济大学附属东方医院泌尿外科, 上海,200120 |
| 摘 要： | 血管内皮生长因子(VEGF)在肾细胞癌组织中高表达,主要受VHL基因和组织缺氧调控,可作为判断肾细胞癌患者肿瘤进展和预后的标志物.近年来将抗VEGF靶向药物用于肾细胞癌治疗,取得良好的临床疗效. |
| 关 键 词： | 血管内皮生长因子类 肾肿瘤 治疗应用 |
Vascular endothelial growth factor and renal cell carcinoma |
|
| ZHOU Shu-kui , WANG Shun-ping , WANG Yue-min. Vascular endothelial growth factor and renal cell carcinoma[J]. Journal of International Oncology, 2012, 39(2): 148-151 | |
| Authors: | ZHOU Shu-kui WANG Shun-ping WANG Yue-min |
| Abstract: | Vascular endothelial growth factor（VEGF）is high expression in the organization of renal cell carcinoma and mainly regulate by VHL gene and hypoxic of organization. Moreover, it can be a biomarker to judge renal cell carcinoma tumor progression and prognostic. In recent years, anti-VEGF targeted drugs are used for the treatment of renal cell carcinoma and receive meaningful clinical benefits. |
| Keywords: | Vascular endothelial growth factors Kidney neoplasms Therapeutic uses |
| 本文献已被 万方数据 等数据库收录！ | |
| 点击此处可从《国际肿瘤学杂志》浏览原始摘要信息 | |
| 点击此处可从《国际肿瘤学杂志》下载全文 | |